TY - JOUR KW - Adult KW - Aged KW - Alleles KW - Cytochrome P-450 CYP2E1 KW - Female KW - Genetic Predisposition to Disease KW - genotype KW - Glutathione Transferase KW - Humans KW - leprosy KW - Male KW - Middle Aged KW - Polymorphism, Single Nucleotide KW - Risk Factors AU - Pinto P AU - Salgado CG AU - Santos N AU - Alencar D AU - Santos S AU - Hutz M AU - Ribeiro-Dos-Santos A AB -
BACKGROUND: The CYP2E1 and GSTM1 genes encode metabolic enzymes that have key functions in drug modification and elimination.
METHODOLOGY/PRINCIPAL FINDINGS: We investigated the possible effects of CYP2E1 and GSTM1 polymorphisms in 71 leprosy patients and in 110 individuals from the general population. The GSTM1*0 null allele and INDEL CYP2E1*1D mutant genotypes were analyzed by conventional PCR, while CYP2E1 SNPs (1053C>T, 1293G>C and 7632T>A) were determined by RT-PCR. In leprosy patients, the GSTM1*0 and CYP2E1*5 alleles and the combined alleles GSTM1*0/CYP2E1*6 and GSTM1*0/CYP2E1*5 were significantly related to a baciloscopic index (BI) (BI<3), while the CYP2E1*6 allele was related to a better clinical evolution in the leprosy spectrum.
CONCLUSIONS/SIGNIFICANCE: Therefore, GSTM1*0, CYP2E1*5 and CYP2E1*6 may be possible protection factors for leprosy patients.
BT - PloS one C1 - http://www.ncbi.nlm.nih.gov/pubmed/23077626?dopt=Abstract CN - PINTO 2012 DA - 2012 DO - 10.1371/journal.pone.0047498 IS - 10 J2 - PLoS ONE LA - eng N2 -BACKGROUND: The CYP2E1 and GSTM1 genes encode metabolic enzymes that have key functions in drug modification and elimination.
METHODOLOGY/PRINCIPAL FINDINGS: We investigated the possible effects of CYP2E1 and GSTM1 polymorphisms in 71 leprosy patients and in 110 individuals from the general population. The GSTM1*0 null allele and INDEL CYP2E1*1D mutant genotypes were analyzed by conventional PCR, while CYP2E1 SNPs (1053C>T, 1293G>C and 7632T>A) were determined by RT-PCR. In leprosy patients, the GSTM1*0 and CYP2E1*5 alleles and the combined alleles GSTM1*0/CYP2E1*6 and GSTM1*0/CYP2E1*5 were significantly related to a baciloscopic index (BI) (BI<3), while the CYP2E1*6 allele was related to a better clinical evolution in the leprosy spectrum.
CONCLUSIONS/SIGNIFICANCE: Therefore, GSTM1*0, CYP2E1*5 and CYP2E1*6 may be possible protection factors for leprosy patients.
PY - 2012 EP - e47498 T2 - PloS one TI - Polymorphisms in the CYP2E1 and GSTM1 genes as possible protection factors for leprosy patients. UR - http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047498 VL - 7 SN - 1932-6203 ER -